Case Report
Published on 29 Jan 2026
HER-2 overexpressing breast cancer during pregnancy: a case report and literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1725927
- 596 views
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,690 articles
articles
Case Report
Published on 29 Jan 2026
Case Report: Long-term control of brain metastases with over 100 cycles of T-DM1 in HER2-positive metastatic breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1778267
- 463 views
Systematic Review
Published on 29 Jan 2026
Elevated thymidine kinase 1 expression at baseline predicts poor prognosis in breast cancer patients
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1666576
- 369 views
Original Research
Published on 28 Jan 2026
Endocrine regimen and early subclinical atherosclerosis in premenopausal HR+/HER2− breast cancer: real-world evidence and regimen-dependent effects of Sanhuang Decoction
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1695776
- 409 views
Case Report
Published on 28 Jan 2026
Case Report: Individualized circulating tumor DNA monitoring guides olaparib adjuvant therapy: an early-stage breast cancer case with somatic BRCA2 mutation
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1679086
- 536 views
Original Research
Published on 27 Jan 2026
ABCA8-positive lipid-metabolic CAFs mediate immunotherapy resistance in TNBC
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1729275
- 578 views
Original Research
Published on 27 Jan 2026
Association between tumor-infiltrating lymphocytes and oncotype DX estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 single gene scores in hormone receptor-positive/HER2-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1677929
- 494 views
Original Research
Published on 27 Jan 2026
Impact of quality control indicator system management program on neoadjuvant and adjuvant therapies for breast cancer: a comparative analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1597546
- 426 views
Case Report
Published on 26 Jan 2026
Case Report: Mixed ductal–lobular carcinoma consisting of invasive lobular carcinoma with a glycogen-rich clear cell pattern and elevated tumor mutation burden
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1741727
- 538 views
Original Research
Published on 26 Jan 2026
Chemotherapy-induced gut microbiota dysbiosis exacerbates cancer-related fatigue in breast cancer patients via neuroimmune-endocrine indicators
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1710457
- 612 views
Correction
Published on 26 Jan 2026
Correction: Vitiligo associated with ribociclib therapy: a rare case report
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1790586
- 245 views
Original Research
Published on 23 Jan 2026
Predicting histological grade in invasive ductal carcinoma of the breast: a radiomics-based machine learning model using DCE-MRI
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1593075
- 587 views
Systematic Review
Published on 23 Jan 2026
Can radiotherapy be omitted in T1-2N1 breast cancer patients after mastectomy without neoadjuvant therapy?
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1726994
- 633 views
Review
Published on 22 Jan 2026
Optimizing second-line endocrine-based treatment in HR positive HER2 negative metastatic breast cancer: a comprehensive expert statement from the Gulf Cooperation Council Region
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1706670
- 1,362 views
Case Report
Published on 21 Jan 2026
Rectal metastasis in a patient with long-term breast cancer: a rare case report with literature review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1597103
- 663 views
Original Research
Published on 21 Jan 2026
Impact of breast cancer genetic testing in Brazilian patients: insights from the MAGENTA study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1597891
- 653 views
Case Report
Published on 21 Jan 2026
Case Report: Mammary Paget’s disease with multifocal microinvasive carcinoma and extensive lymph node metastasis: therapeutic challenges and insights from a case of stage pT1mic pN3c cM0
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1727016
- 679 views
Original Research
Published on 21 Jan 2026
Beyond surface dose: subcutaneous dose escalation underlies TomoTherapy’s skin toxicity in breast radiotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2026.1760716
- 699 views
Original Research
Published on 20 Jan 2026
Dosimetric impact of bolus thickness and immobilization mask use in postmastectomy radiotherapy: a chest wall thickness–based analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1716042
- 564 views
Original Research
Published on 20 Jan 2026
Identification of endogenous reference genes for RT-qPCR analysis in breast cancer and matched adjacent tissues
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1702210
- 709 views
Case Report
Published on 19 Jan 2026
Case Report: Personalized management of HER2-positive breast cancer with advanced nodal disease during pregnancy: a clinical case and review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1672751
- 894 views
Original Research
Accepted on 16 Jan 2026
Circulating Cell-Free DNA as an Integrative Biomarker in Breast Cancer: Correlation with Molecular Subtypes, Mutation Status, and Treatment Response
in Breast Cancer
Frontiers in Oncology
- 686 views
Review
Accepted on 16 Jan 2026
Research Progress on Selective Estrogen Receptor Degraders in the Treatment of Advanced Breast Cancer
in Breast Cancer
Frontiers in Oncology
- 210 views
Original Research
Published on 16 Jan 2026
Ultrasound radiomics predicts preoperative axillary lymph node metastasis status in early-stage breast cancer to support surgical decisions: a machine learning, monocenter study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1680160
- 704 views